CDK4/6 and MAPK—Crosstalk as Opportunity for Cancer Treatment

Title
CDK4/6 and MAPK—Crosstalk as Opportunity for Cancer Treatment
Authors
Keywords
-
Journal
Pharmaceuticals
Volume 13, Issue 12, Pages 418
Publisher
MDPI AG
Online
2020-11-24
DOI
10.3390/ph13120418

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started